丹参川芎嗪注射液治疗脑梗死后椎基底动脉供血不足的临床观察

摘要

目的：探讨丹参川芎嗪注射液治疗脑梗死后椎基底动脉供血不足的临床疗效及安全性。方法：将128例脑梗死后椎基底动脉供血不足患者按随机数字表法分为观察组和对照组，各64例。两组患者均给予一般治疗，对照组患者在一般治疗基础上给予疏血通注射液6 ml加入0.9％氯化钠注射液250 ml中，ivgtt，qd。观察组患者在一般治疗基础上给予丹参川芎嗪注射液10 ml加入0.9％氯化钠注射液250 ml中，ivgtt，qd。两组均连续治疗2周。观察两组患者临床疗效及治疗前后血脂水平、椎基底动脉血流速度和血液黏度指标，并比较两组患者不良反应发生情况。结果：观察组患者总有效率为95.31％，显著高于对照组的79.69％，差异有统计学意义（P＜0.05）。治疗前，两组患者血脂水平、椎基底动脉血流速度、血液黏度指标比较，差异均无统计学意义（P＞0.05）；治疗后，两组患者上述指标均明显改善，观察组患者血脂水平和椎基底动脉血流速度明显低于或快于对照组，差异均有统计学意义（P＜0.05）。两组患者均未见明显不良反应发生。结论：丹参川芎嗪注射液用于治疗脑梗死后椎基底动脉供血不足的疗效显著，能明显改善患者血脂水平、椎基底动脉血流速度和血液黏度，且安全性较好。%OBJECTIVE:To investigate therapeutic efficacy and safety of Salviae miltiorrhizae and ligustrazine hydrochloride injection in the treatment of vertebro-basilar artery insufficiency(VBI)after cerebral infraction. METHODS:128 patients with VBI after cerebral infraction were divided into observation group and control group according to random number table,with 64 cases in each group. Both group received general treatment. Control group was additionally given Shuxuetong injection 6 ml added into 0.9%Sodium chloride injection 250 ml,ivgtt,qd. Observation group was additionally given Salviae miltiorrhizae and ligustrazine hy-drochloride injection 10 ml into 0.9% Sodium chloride injection 250 ml,ivgtt,qd. Both groups received treatment for consecutive 2 weeks. Clinical efficacies of 2 groups were observed as well as blood lipid,vertebro-basilar artery blood velocity and blood viscosity before and after treatment. The occurrence of ADR was compared between 2 groups. RESULTS:The total effective rate of observa-tion group was 95.31%,which was significantly higher than 79.69% of control group,with statistical significance(P0.05). After treatment,above indexes of 2 groups were improved significantly,and blood lipid and vertebro-basilar ar-tery blood velocity of observation group were significantly better than control group,with statistical significance(P<0.05). No obvi-ous ADR was found in 2 groups. CONCLUSIONS:Salviae miltiorrhizae and ligustrazine hydrochloride injection shows significant therapeutic efficacy for VBI after cerebral infraction,can significantly improve blood lipid,vertebro-basilar artery blood velocity and blood viscosity with good safety.